Eurican Herpes 205

RSS

Canine herpes vaccine (inactivated subunit)

Authorised
This medicine is authorised for use in the European Union.

Overview

Eurican Herpes 205 is a veterinary vaccine used to immunise pregnant bitches to prevent mortality, clinical signs and lesions in puppies caused by canine herpes virus infections acquired in the first few days of life.

Eurican Herpes 205 contains the active substance canine herpes virus (F205 strain) antigens.

This EPAR was last updated on 16/02/2021

Authorisation details

Product details
Name
Eurican Herpes 205
Agency product number
EMEA/V/C/000059
Active substance
Canine herpesvirus (F205 strain) antigens
International non-proprietary name (INN) or common name
Canine herpes vaccine (inactivated subunit)
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QI07AA
Publication details
Marketing-authorisation holder
Boehringer Ingelheim Vetmedica GmbH
Revision
12
Date of issue of marketing authorisation valid throughout the European Union
26/03/2001
Contact address

Binger Strasse 173
55216 Ingelheim am Rhein
Germany

Product information

14/08/2020 Eurican Herpes 205 - EMEA/V/C/000059 - IG/1279

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.

 

Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Immunologicals for canidae

Therapeutic indication

Active immunisation of bitches to prevent mortality, clinical signs and lesions in puppies resulting from canine herpes virus infections acquired in the first few days of life.

Assessment history

How useful was this page?

Add your rating